A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes

INTRODUCTION: This 32-week, open-label, randomized, parallel-group, multinational trial aimed to compare the efficacy and safety of stepwise insulin intensification of biphasic insulin aspart 30 (BIAsp 30) relative to stepwise intensification of a basal–bolus regimen in insulin-naïve adults with typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Linjawi, Sultan, Lee, Byung-Wan, Tabak, Ömür, Lövdahl, Susanna, Werther, Shanti, Abusnana, Salahedeen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801220/
https://www.ncbi.nlm.nih.gov/pubmed/29129018
http://dx.doi.org/10.1007/s13300-017-0334-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801220/
https://www.ncbi.nlm.nih.gov/pubmed/29129018
http://dx.doi.org/10.1007/s13300-017-0334-8

Ejemplares similares